Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Lancaster

Showing results (61-70 of 74) with videos related to

Pageof 8
Sort By:
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Chest|November 29, 2016
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical TrialMarilyn K Glassberg, Julia Minkiewicz, Rebecca L Toonkel, et al.
American Journal of Respiratory and Critical Care Medicine|October 28, 2016
Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary FibrosisJonathan A Kropski, Lisa R Young, Joy D Cogan, et al.
Chest|February 17, 2022
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi StudyFranck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|July 25, 2022
The Association between Exposures and Disease Characteristics in Familial Pulmonary FibrosisCarla R Copeland, Edwin F Donnelly, Mitra Mehrad, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary FibrosisWaldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2020
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung DiseaseMargaret L Salisbury, Justin C Hewlett, Guixiao Ding, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
American Journal of Respiratory and Critical Care Medicine|May 11, 2018
Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung DiseaseMeiLan K Han, Emilio Arteaga-Solis, John Blenis, et al.
Pageof 8

Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
The Lancet. Respiratory Medicine|November 24, 2016
Effect of pirfenidone on mortality: pooled analyses and meta-analyses of clinical trials in idiopathic pulmonary fibrosisSteven D Nathan, Carlo Albera, Williamson Z Bradford, et al.
Chest|November 29, 2016
Allogeneic Human Mesenchymal Stem Cells in Patients With Idiopathic Pulmonary Fibrosis via Intravenous Delivery (AETHER): A Phase I Safety Clinical TrialMarilyn K Glassberg, Julia Minkiewicz, Rebecca L Toonkel, et al.
American Journal of Respiratory and Critical Care Medicine|October 28, 2016
Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary FibrosisJonathan A Kropski, Lisa R Young, Joy D Cogan, et al.
Chest|February 17, 2022
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi StudyFranck F Rahaghi, Nicholas A Kolaitis, Ayodeji Adegunsoye, et al.
Annals of the American Thoracic Society|July 25, 2022
The Association between Exposures and Disease Characteristics in Familial Pulmonary FibrosisCarla R Copeland, Edwin F Donnelly, Mitra Mehrad, et al.
American Journal of Respiratory and Critical Care Medicine|March 14, 2024
Phase 2, Double-Blind, Placebo-controlled Trial of a c-Jun N-Terminal Kinase Inhibitor in Idiopathic Pulmonary FibrosisWaldo L L D Mattos, Nasreen Khalil, Lisa G Spencer, et al.
American Journal of Respiratory and Critical Care Medicine|June 30, 2022
A Phase IIb Randomized Clinical Study of an Anti-α<sub>v</sub>β<sub>6</sub> Monoclonal Antibody in Idiopathic Pulmonary FibrosisGanesh Raghu, Majd Mouded, Daniel C Chambers, et al.
American Journal of Respiratory and Critical Care Medicine|February 4, 2020
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung DiseaseMargaret L Salisbury, Justin C Hewlett, Guixiao Ding, et al.
The Lancet. Respiratory Medicine|June 13, 2018
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing studyAmy Dressen, Alexander R Abbas, Christopher Cabanski, et al.
American Journal of Respiratory and Critical Care Medicine|May 11, 2018
Female Sex and Gender in Lung/Sleep Health and Disease. Increased Understanding of Basic Biological, Pathophysiological, and Behavioral Mechanisms Leading to Better Health for Female Patients with Lung DiseaseMeiLan K Han, Emilio Arteaga-Solis, John Blenis, et al.
Pageof 8